The ethical validity and clinical experience of palliative sedation

Mayo Clinic Proceedings

Volumn 75, Issue 10, 2000, Pages 1064-1069

  Paul Rousseau, M D ^a,b  

^a CARL T HAYDEN VA MEDICAL CENTER   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOBARBITAL; BARBITURIC ACID DERIVATIVE; BROMAZEPAM; BROMIDE; CHLORPROMAZINE; CLOMETHIAZOLE; CLONAZEPAM; CODEINE; DIAMORPHINE; DIAZEPAM; FENTANYL; HALOPERIDOL; HYDROMORPHONE; HYDROXYZINE; LEVOMEPROMAZINE; LEVORPHANOL; METHADONE; METHOHEXITAL; MIDAZOLAM; MORPHINE; NEUROLEPTIC AGENT; OPIATE; PENTOBARBITAL; PHENOBARBITAL; PROPOFOL; SCOPOLAMINE; THIOPENTAL; TRANQUILIZER;

AGITATION; CLINICAL PRACTICE; CLINICAL PROTOCOL; DEATH; DELIRIUM; DYING; DYSPNEA; EMOTIONAL STRESS; HUMAN; INFORMED CONSENT; MEDICAL ETHICS; NAUSEA; PAIN; PALLIATIVE THERAPY; PSYCHOSOCIAL CARE; RESPIRATORY DISTRESS; REVIEW; SEDATION; SEIZURE; URINE RETENTION; VOMITING;

EID: 0033795677     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/75.10.1064     Document Type: Review

References (25)

1. Jonsen AR, Siegler M, Winslade WJ. Clinical Ethics: A Practical Approach to Ethical Decisions in Clinical Medicine. 4th ed. New York, NY: McGraw-Hill; 1998.
2. Vacco v Quill, No. 117 SCt 2293 ( 1997).
3. Washington v Glucksberg, No. 117 SCt 2258 ( 1997).
4. Rousseau P. Terminal sedation in the care of dying patients. Arch Intern Med. 1996; 156:1785-1786.
5. Fainsinger RL, Landman W, Hoskings M, Bruera E. Sedation for uncontrolled symptoms in a South African hospice. J Pain Symptom Manage. 1998; 16:145-152.
6. Hallenbeck J. Terminal sedation for intractable distress: not slow euthanasia but a prompt response to .suffering. West J Med. 1999; 171:222-223.
7. Cherny NI, Portenoy RK. Sedation in the management of refractory symploms: guidelines for evaluation and treatment. J Palliat Care. Summer 1994; 10:31-38.
8. Cherny NI. Commentary: sedation in response to refractory existential distress: walking the fine line. J Pain Symptom Manage. 1998:16:404-406.
9. Quill TE. Lo B. Brock DW. Palliative options of last resort: a comparison of voluntarily stopping eating and drinking, terminal sedation, physician-assisted suicide, and voluntary active euthanasia. JAMA. 1997:278:2099-2104.
10. Beauchamp TL, Childress JF. Principles of Biomédical Ethics. 3rd ed. New York, NY: Oxford University Press; 1989.
11. Rousseau PC. Ethical concepts in hospice and palliative medicine. In: Schonwetter RS, Hawke W, eds. Core Curriculum in Hospice ami Palliative Medicine. Dubuque, Iowa: Kendall/Hunt Publishing; 1999:153-158.
12. Ventafridda V. Ripamonti C, De Conno F, Tamburini M, Cassileth BR. Symptom prevalence and control during cancer patients' last days of life. J Palliât Care. Autumn 1990;6:7-l I.
13. Fainsinger R. Miller MJ, Bruera E, Hanson J. Maceachern T. Symptom control during the last week of life on a palliative care unit. J Palliât Care. Spring 1991:7:5-1 I.
14. Greene WR, Davis WH. Titrated intravenous barbiturates in the control of symptoms in patients with terminal cancer. South Med J. 1991:84:332-337.
15. Morita T, Inoue S, Chihara S. Sedation for symptom control in Japan: the importance of intermittent use and communication with family members. J Pain Symptom Manage. 1996; 12:32-38.
16. Stone P, Phillips C, Spruyt O, Waight C. A comparison of the use of sedatives in a hospital support team and in a hospice. Palliât Med. 1997:11:140-144.
17. Fainsinger RL. Use of sedation by a hospital palliative care support team. J Palliât Care. Spring 1998; 14:51-54.
18. Morita T, Tsunoda J, Inoue S, Chihara S. Do hospice clinicians sedate patients intending to hasten death? J Palliai Care. Autumn 1999:15:20-23.
19. Peruselli C, Di Giulio P, Toscani F, et al. Home palliative care for terminal cancer patients: a survey on the final week of life. Palliât Med. 1999;13:233-241.
20. Truog RD, Berde CB, Mitchell C, Grier HE. Barbiturates in the care of the terminally ill. N Engl J Med. 1992;327:1678-1682.
21. Chater S, Viola R, Paterson J, Jarvis V. Sedation for intractable distress in the dying-a survey of experts. Palliât Med. 1998;12: 255-269.
22. Fainsinger RL, Tapper M, Bruera E. A perspective on the management of delirium in terminally ill patients on a palliative care unit. J Palliât Care. Autumn 1993;9:4-8.
23. Rousseau P. Dying and terminal sedation [editorial]. Clin Geriatr. January 1999;7:19-20.
24. Cherny NI, Coyle N, Foley KM. Suffering in the advanced cancer patient: a definition and taxonomy. J Palliât Care. Summer 1994; 10:57-70.
25. Pereira J, Hanson J, Bruera E. The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer. 1997:79:835-842.